サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1324784

単回使用バイオプロセシングの世界市場 - 見通しと予測（2023年～2028年）

Single-use Bioprocessing Market - Global Outlook & Forecast 2023-2028
出版日: | 発行: Arizton Advisory & Intelligence | ページ情報: 英文 395 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
単回使用バイオプロセシングの世界市場 - 見通しと予測（2023年～2028年）
出版日: 2023年08月08日
発行: Arizton Advisory & Intelligence
ページ情報: 英文 395 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の単回使用バイオプロセシングの市場規模は、2022年から2028年にかけてCAGR 19.74％で成長すると予測されています。

技術の進歩は、世界的に新しい単回使用バイオプロセス消耗品を導入する鍵となっています。単回使用バイオプロセシング市場の参入企業は、単回使用バイオプロセシングをこれまで以上に安全、簡単、効率的にする新製品を発売してきました。こうした要因により、各社は市場の需要を満たすことで市場シェアを獲得しています。市場参入企業は、単回使用のディスポーザブルバイオプロセス製品について、斬新なデザインを保護する特許を申請しています。生産用途での単回使用技術の利用可能性が高まり、新製品が発売されることで、企業が迅速かつ容易に技術を採用し、利益を享受し始めることができる環境が整っています。企業は現在、従来の労働集約的な手法を単回使用技術に置き換えることで、コストを削減し、生産プロセスの効率を向上させることができます。

単回使用技術の戦略的買収により、バイオ医薬品全体での導入が促進されます。単回使用技術は、作業を合理化し、廃棄物を削減し、品質管理を向上させる費用対効果の高い効率的な手法です。高品質の単回使用技術を戦略的に獲得することで、企業はコストを削減し効率を高めながら競合優位性を高めることができます。単回使用技術の戦略的取得により、プロセスの可視性と管理が向上し、透明性と業界規制へのコンプライアンスが高まります。単回使用技術の戦略的取得は、コスト削減、効率化、競争優位性の向上を目指す組織にとって強力なツールとなり得る。さらに、業界各社は、地域の単回使用バイオプロセシング市場への参入を促進するため、パートナーシップ戦略を採用しています。

バイオ医薬品とバイオシミラーのバイオ製造能力の増大と取り込みが、単回使用バイオプロセシング市場を牽引しています。単回使用バイオプロセシングは、バイオ医薬品、バイオ治療薬、ワクチン、モノクローナル抗体、バイオシミラーの製造に貴重なプラットフォームを提供します。バイオ製造の進歩に伴い、単回使用バイオプロセシングは、より高い柔軟性、プロセス時間の短縮、スケーラビリティの向上、資本コストの削減、製品汚染リスクの低減を実現しています。さらに、単回使用バイオプロセシングでは、機器の大掛かりな洗浄や滅菌が不要なため、運用コストも削減できます。

当レポートでは、世界の単回使用バイオプロセシング市場について調査し、市場の概要とともに、製品タイプ別、用途別、エンドユーザー別、手法別、ワークフロー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 調査の目的

第3章 調査プロセス

第4章 範囲と適用範囲

  • 市場の定義
  • 基準年
  • 調査範囲

第5章 レポートの前提条件と注意事項

第6章 重要考察

第7章 市場の概要

第8章 イントロダクション

第9章 市場機会と動向

  • 細胞および遺伝子治療におけるディスポーザブル技術
  • 継続的なバイオプロセスの需要増大
  • ディスポーザブルバイオプロセス（サブ）における技術の進歩
  • 新製品の発売
  • 戦略的な買収とコラボレーションの増加

第10章 市場成長促進要因

第11章 市場成長抑制要因

第12章 市場情勢

  • 市場概要
  • 市場規模と予測
  • 市場機会
    • 製品別市場
    • 用途別市場
    • エンドユーザー別市場
    • 手法別市場
    • ワークフロー別市場
    • 地域別市場
  • ファイブフォース分析

第13章 製品タイプ

  • 市場のスナップショットと成長促進要因
  • 市場概要
  • ディスポーザブルバイオプロセス装置
  • シンプル・周辺機器

第14章 用途

  • 市場のスナップショットと成長促進要因
  • 市場概要
  • モノクローナル抗体
  • ワクチン
  • 細胞療法
  • その他

第15章 エンドユーザー

  • 市場のスナップショットと成長促進要因
  • 市場概要
  • バイオ医薬品メーカー
  • 製造受託機関（CMO）
  • 研究開発企業・研究機関

第16章 手法

  • 市場のスナップショットと成長促進要因
  • 市場概要
  • 濾過
  • 保管と輸送
  • 細胞培養
  • 混合
  • 精製

第17章 ワークフロー

  • 市場のスナップショットと成長促進要因
  • 市場概要
  • 上流
  • 下流

第18章 地域

第19章 北米

第20章 欧州

第21章 アジア太平洋

第22章 ラテンアメリカ

第23章 中東・アフリカ

第24章 競合情勢

  • 競合の概要
  • 市場シェア分析
    • THERMO FISHER SCIENTIFIC
    • SARTORIUS STEDIM BIOTECH
    • DANAHER
    • MERCK KGAA
    • AVANTOR

第25章 主要な企業プロファイル

  • THERMO FISHER SCIENTIFIC
  • SARTORIUS STEDIM BIOTECH
  • DANAHER
  • MERCK KGAA
  • AVANTOR

第26章 その他の著名なベンダー

  • 3I GROUP
  • 3M
  • ABEC
  • ADOLF KUHNER
  • ADVANTAPURE
  • BARRY-WEHMILLER COMPANIES
  • BROADLEY-JAMES
  • CELLTAINER BIOTECH
  • CERCELL A/S
  • CESCO BIOENGINEERING
  • CHARTER MEDICAL
  • COLDER PRODUCTS COMPANY
  • CORNING
  • DISTEK
  • DRM, DR. MUELLER
  • EMERSON ELECTRIC
  • ENTEGRIS
  • EPPENDORF
  • FOXX LIFE SCIENCES
  • GETINGE
  • HIGH-PURITY NEW ENGLAND
  • HOLLAND APPLIED TECHNOLOGIES
  • LONZA
  • MEISSNER FILTRATION PRODUCTS
  • NEW HORIZON BIOTECH
  • OMNIBRX BIOTECHNOLOGIES
  • PARKER HANNIFIN
  • PENDOTECH
  • PBS BIOTECH
  • REPLIGEN
  • SAINT-GOBAIN
  • SENTINEL PROCESS SYSTEMS
  • SOLARIS BIOTECHNOLOGY
  • SYSBIOTECH
  • WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS
  • WEIGAO GROUP
  • W.L. GORE & ASSOCIATES

第27章 レポートの概要

第28章 定量的概要

第29章 付録

目次
Product Code: ARZ230614

The global single-use bioprocessing market is expected to grow at a CAGR of 19.74% from 2022 to 2028.

MARKET TRENDS & DRIVERS

New Product Launches

Technological advances have been key in introducing new single-use bioprocess consumables worldwide. Players in the single-use bioprocessing market have launched new products that make single-use bioprocessing safer, easier, and more efficient than ever before. Such factors have allowed companies to gain market share by meeting market demands. Market participants apply for patents on single-use disposable bioprocessing products that protect novel designs. The increasing availability of single-use technology for production applications and the launch of new products creates an environment where companies can quickly and easily adopt the technology and begin reaping the benefits. Companies can now reduce costs and improve efficiency in their production processes by replacing traditional, labor-intensive methods with single-use technology.

Increasing Strategic Acquisitions and Collaborations

The strategic acquisition of single-use technology can enhance adoption across biopharmaceuticals. Single-use technology is a cost-effective and efficient way to streamline operations, reduce waste, and improve quality control. By strategically acquiring high-quality single-use technology, organizations can increase their competitive advantage while reducing costs and increasing efficiency. The strategic acquisition of single-use technology can increase the visibility and control of processes, resulting in increased transparency and compliance with industry regulations. The strategic acquisition of single-use technology can be a powerful tool for organizations looking to reduce costs, increase efficiency, and improve their competitive advantage. In addition, the industry players are adopting partnership strategies to facilitate access to local single-use bioprocessing markets.

Growing Biomanufacturing Capacity and Uptake of Biopharmaceuticals & Biosimilars

The growing biomanufacturing capacity and uptake of biopharmaceuticals and biosimilars drive the single-use bioprocessing market. Single-use bioprocessing provides a valuable platform for producing biopharmaceuticals, biotherapeutics, vaccines, monoclonal antibodies, and biosimilars. With advances in biomanufacturing, single-use bioprocessing offers greater flexibility, shorter process times, improved scalability, lower capital costs, and reduced product contamination risks. Additionally, single-use bioprocessing eliminates the need for extensive cleaning and sterilization of equipment, thus reducing operational costs.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT TYPE

Single-use bioprocessing equipment is a technology that has revolutionized the biopharmaceutical industry. This technology has increased efficiency, flexibility, safety, and cost savings during bioprocessing. Single-use bioprocessing equipment is a system of technologies designed to replace reusable stainless steel and other materials traditionally used in bioprocessing. This equipment uses single-use components, including bags, bioreactors, tubing, syringes, connectors, and filters, disposed of after use. In 2022, the single-use bioprocessing equipment product type held a larger share of the global single-use bioprocessing market.

Segmentation by Product Type

  • Single-use Bioprocessing Equipment
  • Simple & Peripheral Devices

INSIGHTS BY APPLICATION

The global single-use bioprocessing market by application is segmented as monoclonal antibodies (mABs), vaccines, cell therapies, and others. Monoclonal antibodies (mABs) hold the largest industry share by application segment. Single-use bioprocessing is an emerging technology in the biopharmaceutical industry that has revolutionized how monoclonal antibodies (mAbs) are produced. Single-use bioprocessing involves using disposable bioreactors and other components to produce proteins, such as mAbs. Unlike traditional stainless-steel bioreactors, single-use bioreactors can be quickly set up, require minimal cleaning, and reduce the risk of cross-contamination. Due to their complexity and high cost, these advantages make single-use bioprocessing particularly attractive for mAb production.

Segmentation by Application

  • Monoclonal Antibodies (mABs)
  • Vaccines
  • Cell Therapies
  • Others

INSIGHTS BY END-USER

The biopharmaceutical manufacturers segment accounted for over 39% of the global single-use bioprocessing market. This segment dominates the overall market and will likely retain its dominance in the coming years due to its widespread adoption in research and commercial manufacturing applications. Several biopharmaceutical manufacturers have already explored SUB solutions usage in commercial manufacturing. However, their potential benefits are significant, particularly in small-volume manufacturing in modular facilities. Most biopharmaceutical manufacturers, especially large and medium-sized companies, spend over $50 million on equipment annually. It has been witnessed that a high percentage of capital is being spent on single-use bioprocessing by biopharmaceutical manufacturers.

Segmentation by End-users

  • Biopharmaceutical Manufacturers
  • Contract Manufacturing Organizations (CMOs)
  • R&D Companies & Research Institutes

INSIGHTS BY METHOD

The global single-use bioprocessing market by the method is categorized as filtration, storage & transport, cell culture, mixing, and purification. Filtration holds the largest share of the market. Single-use bioprocessing is a method of filtration that has grown increasingly popular in the biotechnology industry. It involves using disposable, self-contained systems to prepare, filter, and process bioproducts. This form of filtration has many advantages, especially for pharmaceutical and biological product manufacturing. Single-use bioprocessing has revolutionized the biotechnology industry. This reduces the need for traditional equipment and infrastructure, resulting in cost savings and improved production efficiency.

Segmentation by Method

  • Filtration
  • Storage & Transport
  • Cell Culture
  • Mixing
  • Purification

INSIGHTS BY WORKFLOW

The upstream workflow segment dominated the global single-use bioprocessing market. Upstream single-use bioprocessing workflow is focused on upstream unit operations such as cell culture, protein expression, and harvest. Over the last decade, advances in this workflow have enabled biopharmaceutical companies to streamline the process, increase product yields, and reduce costs. The upstream single-use bioprocessing workflow advancements have provided biopharmaceutical companies with a more efficient and cost-effective workflow.

Segmentation by Workflow

  • Upstream
  • Downstream

GEOGRAPHICAL ANALYSIS

The single-use bioprocessing market in North America is growing significantly and is expected to grow at a similar pace during the forecast period. Increasing demand for biologics from patients, especially the elderly, high investments in R&D activities by biopharmaceutical companies, and patent expiries of biologics are the key drivers for the single-use bioprocessing market in North America. North America, especially the U.S., is known for its in-house biopharmaceutical manufacturing facilities, which have bolstered the adoption of disposables (simple and peripheral devices) and highly advanced single-use systems such as mixing systems, bioreactors, and cell culture systems over the past few years.

Segmentation by Geography

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Switzerland
    • The U.K.
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • Australia
    • South Korea
    • India
  • Latin America
    • Brazil
    • Mexico
    • Colombia
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • South Africa

VENDOR LANDSCAPE

The global single-use bioprocessing market is highly dynamic and offers significant growth opportunities for vendors. Although the industry is characterized by the presence of several global as well as local players, a few major global players hold significant shares, offering a broad range of SUTs. As the market offers tremendous growth opportunities, new players are expected to enter, intensifying the competition. Rising competition among SUT manufacturers is expected to drive significant product development, such as providing single-use bioreactors with large manufacturing volumes and capacities.

Key Company Profiles

  • Thermo Fisher Scientific
  • Sartorius Stedim Biotech
  • Danaher
  • Merck KGaA
  • Avantor

Other Prominent Vendors

  • 3i Group
  • 3M
  • ABEC
  • Adolf Kuhner
  • AdvantaPure
  • Barry-Wehmiller Companies
  • Broadley-James
  • Celltainer Biotech
  • CerCell A/S
  • CESCO Bioengineering
  • Charter Medical
  • Colder Products Company
  • Corning
  • Distek
  • DrM, Dr. Mueller
  • Emerson Electric
  • Entegris
  • Eppendorf
  • Foxx Life Sciences
  • Getinge
  • HIGH PURITY NEW ENGLAND
  • Holland Applied Technologies
  • Lonza
  • MEISSNER FILTRATION PRODUCTS
  • New Horizon Biotech
  • OmniBRx Biotechnologies
  • PARKER HANNIFIN
  • PendoTECH
  • PBS Biotech
  • Repligen
  • Saint-Gobain
  • Sentinel Process Systems
  • Solaris Biotechnology
  • SYSBIOTECH GmbH
  • Watson-Marlow Fluid Technology Solutions
  • Weigao Group
  • W.L. Gore & Associates

KEY QUESTIONS ANSWERED:

  • 1. How big is the global single-use bioprocessing market?
  • 2. What is the growth rate of the single-use bioprocessing market?
  • 3. What are the rising trends in the single-use bioprocessing market?
  • 4. Which region holds the most significant global single-use bioprocessing market share?
  • 5. Who are the key players in the global single-use bioprocessing market?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY PRODUCT
    • 4.3.2 MARKET SEGMENTATION BY APPLICATION
    • 4.3.3 MARKET SEGMENTATION BY END-USERS
    • 4.3.4 MARKET SEGMENTATION BY METHOD
    • 4.3.5 MARKET SEGMENTATION BY WORKFLOW
    • 4.3.6 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

  • 6.1 MARKET OVERVIEW
    • 6.1.1 GEOGRAPHY INSIGHTS
    • 6.1.2 PRODUCT TYPE INSIGHTS
    • 6.1.3 APPLICATION INSIGHTS
    • 6.1.4 END-USER INSIGHTS
    • 6.1.5 METHOD INSIGHTS
    • 6.1.6 WORKFLOW INSIGHTS

7 MARKET AT A GLANCE

8 INTRODUCTION

  • 8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 SINGLE-USE TECHNOLOGY IN CELL AND GENE THERAPY
  • 9.2 INCREASING DEMAND FOR CONTINUOUS BIOPROCESSING
  • 9.3 TECHNOLOGICAL ADVANCES IN SINGLE-USE BIOPROCESSING (SUB)
  • 9.4 NEW PRODUCT LAUNCHES
  • 9.5 INCREASING STRATEGIC ACQUISITIONS AND COLLABORATIONS

10 MARKET GROWTH ENABLERS

  • 10.1 GROWING BIOMANUFACTURING CAPACITY AND UPTAKE OF BIOPHARMACEUTICALS & BIOSIMILARS
  • 10.2 LOWER CAPITAL INVESTMENT IN SUTS OVER MULTI-USE PLATFORMS AND LESS FLOOR SPACE REQUIREMENTS
  • 10.3 INCREASED ACCEPTANCE OF SUS TO ENHANCE BIOMANUFACTURING PRODUCTIVITY AND EFFICIENCY
  • 10.4 REDUCED WATER CONSUMPTION AND LESSER ENVIRONMENTAL IMPACT OF SINGLE-USE TECHNOLOGIES

11 MARKET RESTRAINTS

  • 11.1 THE CHANGING SCALE OF SINGLE-USE OPERATIONS
  • 11.2 LOW STRENGTH OF SUPPLY CHAIN AND LACK OF STANDARDIZATION
  • 11.3 ISSUES RELATED TO LEACHABLES AND EXTRACTABLES

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
  • 12.3 MARKET OPPORTUNITY
    • 12.3.1 MARKET BY PRODUCT
    • 12.3.2 MARKET BY APPLICATION
    • 12.3.3 MARKET BY END-USER
    • 12.3.4 MARKET BY METHOD
    • 12.3.5 MARKET BY WORKFLOW
    • 12.3.6 MARKET BY GEOGRAPHY
  • 12.4 FIVE FORCES ANALYSIS
    • 12.4.1 THREAT OF NEW ENTRANTS
    • 12.4.2 BARGAINING POWER OF SUPPLIERS
    • 12.4.3 BARGAINING POWER OF BUYERS
    • 12.4.4 THREAT OF SUBSTITUTES
    • 12.4.5 COMPETITIVE RIVALRY

13 PRODUCT TYPE

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 SINGLE-USE BIOPROCESSING EQUIPMENT
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 SINGLE-USE BIOPROCESSING EQUIPMENT MARKET BY GEOGRAPHY
  • 13.4 SIMPLE & PERIPHERAL DEVICES
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 SIMPLE & PERIPHERAL DEVICES MARKET BY GEOGRAPHY

14 APPLICATION

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 MONOCLONAL ANTIBODIES
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MONOCLONAL ANTIBODIES (MABS) MARKET BY GEOGRAPHY
  • 14.4 VACCINES
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 VACCINES MARKET BY GEOGRAPHY
  • 14.5 CELL THERAPIES
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 CELL THERAPIES MARKET BY GEOGRAPHY
  • 14.6 OTHERS
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST
    • 14.6.3 OTHERS MARKET BY GEOGRAPHY

15 END-USER

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 BIOPHARMACEUTICAL MANUFACTURERS
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 BIOPHARMACEUTICAL MANUFACTURERS MARKET BY GEOGRAPHY
  • 15.4 CONTRACT MANUFACTURING ORGANIZATIONS (CMO)
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) MARKET BY GEOGRAPHY
  • 15.5 R&D COMPANIES AND RESEARCH INSTITUTES
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST
    • 15.5.3 R&D COMPANIES AND RESEARCH INSTITUTES MARKET BY GEOGRAPHY

16 METHOD

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 MARKET OVERVIEW
  • 16.3 FILTRATION
    • 16.3.1 MARKET OVERVIEW
    • 16.3.2 MARKET SIZE & FORECAST
  • 16.4 STORAGE & TRANSPORT
    • 16.4.1 MARKET OVERVIEW
    • 16.4.2 MARKET SIZE & FORECAST
  • 16.5 CELL CULTURE
    • 16.5.1 MARKET OVERVIEW
    • 16.5.2 MARKET SIZE & FORECAST
  • 16.6 MIXING
    • 16.6.1 MARKET OVERVIEW
    • 16.6.2 MARKET SIZE & FORECAST
  • 16.7 PURIFICATION
    • 16.7.1 MARKET OVERVIEW
    • 16.7.2 MARKET SIZE & FORECAST

17 WORKFLOW

  • 17.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 17.2 MARKET OVERVIEW
  • 17.3 UPSTREAM
    • 17.3.1 MARKET OVERVIEW
    • 17.3.2 MARKET SIZE & FORECAST
  • 17.4 DOWNSTREAM
    • 17.4.1 MARKET OVERVIEW
    • 17.4.2 MARKET SIZE & FORECAST

18 GEOGRAPHY

  • 18.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 18.2 GEOGRAPHIC OVERVIEW

19 NORTH AMERICA

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
    • 19.2.1 NORTH AMERICA MARKET BY PRODUCT TYPE
    • 19.2.2 NORTH AMERICA MARKET BY APPLICATION
    • 19.2.3 NORTH AMERICA MARKET BY END-USER
  • 19.3 KEY COUNTRIES
    • 19.3.1 US: MARKET SIZE & FORECAST
    • 19.3.2 CANADA: MARKET SIZE & FORECAST

20 EUROPE

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
    • 20.2.1 EUROPE MARKET BY PRODUCT TYPE
    • 20.2.2 EUROPE MARKET BY APPLICATION
    • 20.2.3 EUROPE MARKET BY END-USER
  • 20.3 KEY COUNTRIES
    • 20.3.1 GERMANY: MARKET SIZE & FORECAST
    • 20.3.2 FRANCE: MARKET SIZE & FORECAST
    • 20.3.3 SWITZERLAND: MARKET SIZE & FORECAST
    • 20.3.4 UK: MARKET SIZE & FORECAST
    • 20.3.5 ITALY: MARKET SIZE & FORECAST
    • 20.3.6 SPAIN: MARKET SIZE & FORECAST

21 APAC

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
    • 21.2.1 APAC MARKET BY PRODUCT TYPE
    • 21.2.2 APAC MARKET BY APPLICATION
    • 21.2.3 APAC MARKET BY END-USER
  • 21.3 KEY COUNTRIES
    • 21.3.1 CHINA: MARKET SIZE & FORECAST
    • 21.3.2 JAPAN: MARKET SIZE & FORECAST
    • 21.3.3 AUSTRALIA: MARKET SIZE & FORECAST
    • 21.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 21.3.5 INDIA: MARKET SIZE & FORECAST

22 LATIN AMERICA

  • 22.1 MARKET OVERVIEW
  • 22.2 MARKET SIZE & FORECAST
    • 22.2.1 LATIN AMERICA MARKET BY PRODUCT TYPE
    • 22.2.2 LATIN AMERICA MARKET BY APPLICATION
    • 22.2.3 LATIN AMERICA MARKET BY END-USER
  • 22.3 KEY COUNTRIES
    • 22.3.1 BRAZIL: MARKET SIZE & FORECAST
    • 22.3.2 MEXICO: MARKET SIZE & FORECAST
    • 22.3.3 COLOMBIA: MARKET SIZE & FORECAST
    • 22.3.4 ARGENTINA: MARKET SIZE & FORECAST

23 MIDDLE EAST & AFRICA

  • 23.1 MARKET OVERVIEW
  • 23.2 MARKET SIZE & FORECAST
    • 23.2.1 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
    • 23.2.2 MIDDLE EAST & AFRICA MARKET BY APPLICATION
    • 23.2.3 MIDDLE EAST & AFRICA MARKET BY END-USER
  • 23.3 KEY COUNTRIES
    • 23.3.1 TURKEY: MARKET SIZE & FORECAST
    • 23.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 23.3.3 UAE: MARKET SIZE & FORECAST
    • 23.3.4 SOUTH AFRICA: MARKET SIZE & FORECAST

24 COMPETITIVE LANDSCAPE

  • 24.1 COMPETITION OVERVIEW
    • 24.1.1 VENDOR ACTIVITIES IN SINGLE-USE BIOPROCESSING MARKET
  • 24.2 MARKET SHARE ANALYSIS
    • 24.2.1 THERMO FISHER SCIENTIFIC
    • 24.2.2 SARTORIUS STEDIM BIOTECH
    • 24.2.3 DANAHER
    • 24.2.4 MERCK KGAA
    • 24.2.5 AVANTOR

25 KEY COMPANY PROFILES

  • 25.1 THERMO FISHER SCIENTIFIC
    • 25.1.1 BUSINESS OVERVIEW
    • 25.1.2 PRODUCT OFFERINGS
    • 25.1.3 KEY STRATEGIES
    • 25.1.4 KEY STRENGTHS
    • 25.1.5 KEY OPPORTUNITIES
  • 25.2 SARTORIUS STEDIM BIOTECH
    • 25.2.1 BUSINESS OVERVIEW
    • 25.2.2 PRODUCT OFFERINGS
    • 25.2.3 KEY STRATEGIES
    • 25.2.4 KEY STRENGTHS
    • 25.2.5 KEY OPPORTUNITIES
  • 25.3 DANAHER
    • 25.3.1 BUSINESS OVERVIEW
    • 25.3.2 PRODUCT OFFERINGS
    • 25.3.3 KEY STRATEGIES
    • 25.3.4 KEY STRENGTHS
    • 25.3.5 KEY OPPORTUNITIES
  • 25.4 MERCK KGAA
    • 25.4.1 BUSINESS OVERVIEW
    • 25.4.2 PRODUCT OFFERINGS
    • 25.4.3 KEY STRATEGIES
    • 25.4.4 KEY STRENGTHS
    • 25.4.5 KEY OPPORTUNITIES
  • 25.5 AVANTOR
    • 25.5.1 BUSINESS OVERVIEW
    • 25.5.2 PRODUCT OFFERINGS
    • 25.5.3 KEY STRATEGIES
    • 25.5.4 KEY STRENGTHS
    • 25.5.5 KEY OPPORTUNITIES

26 OTHER PROMINENT VENDORS

  • 26.1 3I GROUP
    • 26.1.1 BUSINESS OVERVIEW
    • 26.1.2 PRODUCT OFFERINGS
  • 26.2 3M
    • 26.2.1 BUSINESS OVERVIEW
    • 26.2.2 PRODUCT OFFERINGS
  • 26.3 ABEC
    • 26.3.1 BUSINESS OVERVIEW
    • 26.3.2 PRODUCT OFFERINGS
  • 26.4 ADOLF KUHNER
    • 26.4.1 BUSINESS OVERVIEW
    • 26.4.2 PRODUCT OFFERINGS
  • 26.5 ADVANTAPURE
    • 26.5.1 BUSINESS OVERVIEW
    • 26.5.2 PRODUCT OFFERINGS
  • 26.6 BARRY-WEHMILLER COMPANIES
    • 26.6.1 BUSINESS OVERVIEW
    • 26.6.2 PRODUCT OFFERING
  • 26.7 BROADLEY-JAMES
    • 26.7.1 BUSINESS OVERVIEW
    • 26.7.2 PRODUCT OFFERINGS
  • 26.8 CELLTAINER BIOTECH
    • 26.8.1 BUSINESS OVERVIEW
    • 26.8.2 PRODUCT OFFERINGS
  • 26.9 CERCELL A/S
    • 26.9.1 BUSINESS OVERVIEW
    • 26.9.2 PRODUCT OFFERINGS
  • 26.10 CESCO BIOENGINEERING
    • 26.10.1 BUSINESS OVERVIEW
    • 26.10.2 PRODUCT OFFERINGS
  • 26.11 CHARTER MEDICAL
    • 26.11.1 BUSINESS OVERVIEW
    • 26.11.2 PRODUCT OFFERINGS
  • 26.12 COLDER PRODUCTS COMPANY
    • 26.12.1 BUSINESS OVERVIEW
    • 26.12.2 PRODUCT OFFERINGS
  • 26.13 CORNING
    • 26.13.1 BUSINESS OVERVIEW
    • 26.13.2 PRODUCT OFFERINGS
  • 26.14 DISTEK
    • 26.14.1 BUSINESS OVERVIEW
    • 26.14.2 PRODUCT OFFERINGS
  • 26.15 DRM, DR. MUELLER
    • 26.15.1 BUSINESS OVERVIEW
    • 26.15.2 PRODUCT OFFERINGS
  • 26.16 EMERSON ELECTRIC
    • 26.16.1 BUSINESS OVERVIEW
    • 26.16.2 PRODUCT OFFERINGS
  • 26.17 ENTEGRIS
    • 26.17.1 BUSINESS OVERVIEW
    • 26.17.2 PRODUCT OFFERINGS
  • 26.18 EPPENDORF
    • 26.18.1 BUSINESS OVERVIEW
    • 26.18.2 PRODUCT OFFERINGS
  • 26.19 FOXX LIFE SCIENCES
    • 26.19.1 BUSINESS OVERVIEW
    • 26.19.2 PRODUCT OFFERINGS
  • 26.20 GETINGE
    • 26.20.1 BUSINESS OVERVIEW
    • 26.20.2 PRODUCT OFFERINGS
  • 26.21 HIGH-PURITY NEW ENGLAND
    • 26.21.1 BUSINESS OVERVIEW
    • 26.21.2 PRODUCT OFFERINGS
  • 26.22 HOLLAND APPLIED TECHNOLOGIES
    • 26.22.1 BUSINESS OVERVIEW
    • 26.22.2 PRODUCT OFFERINGS
  • 26.23 LONZA
    • 26.23.1 BUSINESS OVERVIEW
    • 26.23.2 PRODUCT OFFERINGS
  • 26.24 MEISSNER FILTRATION PRODUCTS
    • 26.24.1 BUSINESS OVERVIEW
    • 26.24.2 PRODUCT OFFERINGS
  • 26.25 NEW HORIZON BIOTECH
    • 26.25.1 BUSINESS OVERVIEW
    • 26.25.2 PRODUCT OFFERINGS
  • 26.26 OMNIBRX BIOTECHNOLOGIES
    • 26.26.1 BUSINESS OVERVIEW
    • 26.26.2 PRODUCT OFFERINGS
  • 26.27 PARKER HANNIFIN
    • 26.27.1 BUSINESS OVERVIEW
    • 26.27.2 PRODUCT OFFERINGS
  • 26.28 PENDOTECH
    • 26.28.1 BUSINESS OVERVIEW
    • 26.28.2 PRODUCT OFFERINGS
  • 26.29 PBS BIOTECH
    • 26.29.1 BUSINESS OVERVIEW
    • 26.29.2 PRODUCT OFFERINGS
  • 26.30 REPLIGEN
    • 26.30.1 BUSINESS OVERVIEW
    • 26.30.2 PRODUCT OFFERINGS
  • 26.31 SAINT-GOBAIN
    • 26.31.1 BUSINESS OVERVIEW
    • 26.31.2 PRODUCT OFFERINGS
  • 26.32 SENTINEL PROCESS SYSTEMS
    • 26.32.1 BUSINESS OVERVIEW
    • 26.32.2 PRODUCT OFFERINGS
  • 26.33 SOLARIS BIOTECHNOLOGY
    • 26.33.1 BUSINESS OVERVIEW
    • 26.33.2 PRODUCT OFFERINGS
  • 26.34 SYSBIOTECH
    • 26.34.1 BUSINESS OVERVIEW
    • 26.34.2 PRODUCT OFFERINGS
  • 26.35 WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS
    • 26.35.1 BUSINESS OVERVIEW
    • 26.35.2 PRODUCT OFFERINGS
  • 26.36 WEIGAO GROUP
    • 26.36.1 BUSINESS OVERVIEW
    • 26.36.2 PRODUCT OFFERINGS
  • 26.37 W.L. GORE & ASSOCIATES
    • 26.37.1 BUSINESS OVERVIEW
    • 26.37.2 PRODUCT OFFERINGS

27 REPORT SUMMARY

  • 27.1 KEY TAKEAWAYS
  • 27.2 STRATEGIC RECOMMENDATIONS

28 QUANTITATIVE SUMMARY

  • 28.1 MARKET BY PRODUCT TYPE
    • 28.1.1 NORTH AMERICA MARKET BY PRODUCT TYPE
    • 28.1.2 EUROPE MARKET BY PRODUCT TYPE
    • 28.1.3 APAC MARKET BY PRODUCT TYPE
    • 28.1.4 LATIN AMERICA MARKET BY PRODUCT TYPE
    • 28.1.5 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
  • 28.2 MARKET BY APPLICATION
    • 28.2.1 NORTH AMERICA MARKET BY APPLICATION
    • 28.2.2 EUROPE MARKET BY APPLICATION
    • 28.2.3 APAC MARKET BY APPLICATION
    • 28.2.4 LATIN AMERICA MARKET BY APPLICATION
    • 28.2.5 MIDDLE EAST & AFRICA MARKET BY APPLICATION
  • 28.3 MARKET BY END-USER
    • 28.3.1 NORTH AMERICA MARKET BY END-USER
    • 28.3.2 EUROPE MARKET BY END-USER
    • 28.3.3 APAC MARKET BY END-USER
    • 28.3.4 LATIN AMERICA MARKET BY END-USER
    • 28.3.5 MIDDLE EAST & AFRICA MARKET BY END-USER
  • 28.4 MARKET BY METHOD
  • 28.5 MARKET BY WORKFLOW
  • 28.6 MARKET BY GEOGRAPHY
    • 28.6.1 SINGLE-USE BIOPROCESSING EQUIPMENT MARKET BY GEOGRAPHY
    • 28.6.2 SIMPLE & PERIPHERAL DEVICES MARKET BY GEOGRAPHY
    • 28.6.3 MONOCLONAL ANTIBODIES (MABS) MARKET BY GEOGRAPHY
    • 28.6.4 VACCINES MARKET BY GEOGRAPHY
    • 28.6.5 CELL THERAPIES MARKET BY GEOGRAPHY
    • 28.6.6 OTHERS MARKET BY GEOGRAPHY
    • 28.6.7 BIOPHARMACEUTICAL MANUFACTURERS MARKET BY GEOGRAPHY
    • 28.6.8 CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) MARKET BY GEOGRAPHY
    • 28.6.9 R&D COMPANIES AND RESEARCH INSTITUTES MARKET BY GEOGRAPHY

29 APPENDIX

  • 29.1 ABBREVIATIONS